Navigation Links
Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
Date:2/11/2008

PALO ALTO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced that its Board of Directors has authorized the repurchase of up to $100 million in shares of its common stock. The new repurchase program is effective until December 31, 2009.

"This share repurchase program is another example of our continued focus on capital allocation management to enhance long-term value for our shareholders," said G. Edward McClammy, Senior Vice President, Chief Financial Officer and Treasurer. "With the strength of our cash position, balance sheet and cash flow, we have the financial capacity to complete this repurchase authorization and continue our strategy of acquiring businesses that complement our existing product range."

Stock repurchases under this program may be made in the open market or in private transactions, at times and in amounts that management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price and regulatory requirements.

The Company's previous $100 million stock repurchase program, which was approved in January 2007 and effective until December 31, 2008, was completed in February 2008. Under that program, the Company repurchased 1,738,100 shares of its common stock, including 667,860 shares repurchased for $36.1 million in the current quarter. As of December 28, 2007, the Company had 30,430,249 common shares outstanding.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For Information Contact:

Investor Relations

Varian, Inc.

650.424.5471

ir@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Varian, Inc. CEO to Speak at JPMorgan Healthcare Conference
2. Varian, Inc. Acquires Analogix Business
3. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
4. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
5. Brookdale Senior Living Announces Changes in Senior Management and Board of Directors
6. Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members
7. Lupus Foundation of America Launches Website Message Boards to Connect People With Lupus
8. ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member
9. AtriCure Appoints Mark A. Collar to its Board of Directors
10. Survey Reveals Most Pet Owners Consider Kennel Boarding a Necessary Evil; Pet Care Industry Shortcomings Spawn Improved Approach
11. Staples Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... A local ... that more than 40 percent of participating fifth-grade students already have or are ... and Asthma Clinical Research in the Division of Pulmonary, Allergy and Critical Care ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... , ... May 05, 2016 , ... The 2016 Nike ... Derek Pittman, along with his university coaching staff. Together they bring their winning Vandals ... sessions run for youth players ages 5-13, and high school players. Session dates are ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy ... alleviate the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies ... with arthritis. , “Physical therapy exercises are commonly prescribed to individuals with ...
(Date:5/5/2016)... ... May 05, 2016 , ... The Lung Institute will celebrate its three-year ... seminar at most clinic locations throughout the month of May. To date, the Lung Institute ... rapid growth that we’ve seen is a testament to the success of this treatment and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology: